Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab with or without IVIG in Pemphigus
NCT04400994Phase 2Active, not recruiting
- Sponsor
- The University of Hong Kong
- Start
- Jun 2020
- Primary completion
- Dec 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of intravenous immunoglobulin G in pemphigus vulgaris (PV), pemphigus foliaceus (PF), sponsored by The University of Hong Kong. Started Jun 2020; status: active, not recruiting.
02
Drugs
intravenous immunoglobulin G
03
Conditions
pemphigus vulgaris (PV)pemphigus foliaceus (PF)
Beyond the preview
Go deeper on NCT04400994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04400994.